Logo Logo

Publications by Unterhalt, Michael

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 40.

Journal article

Kluin-Nelemans, Hanneke C.; Hoster, Eva; Hermine, Olivier; Walewski, Jan; Geisler, Christian H.; Trneny, Marek; Stilgenbauer, Stephan; Kaiser, Florian; Doorduijn, Jeanette K.; Salles, Gilles; Szymczyk, Michal; Tilly, Herve; Ribrag, Vincent; Klapper, Wolfram; Pott, Christiane; Unterhalt, Michael; Dreyling, Martin; Kanz, Lothar; Schmidt, Christian; Feugier, Pierre; Thieblemont, Catherine; Zijlstra, Josee M. (2020): Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial. In: Journal of Clinical Oncology, Vol. 38, No. 3: pp. 248-256

Rauert-Wunderlich, Hilka; Mottok, Anja; Scott, David W.; Rimsza, Lisa M.; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Hartmann, Sylvia; Thorns, Christoph; Rymkiewicz, Grzegorz; Holte, Harald; Dreyling, Martin; Hoster, Eva; Rosenwald, Andreas (February 2019): Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network. In: British Journal of Haematology, Vol. 184, No. 4

Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Haebe, Sarah; Schmidt, Christian; Zoellner, Anna-Katharina; Dreyling, Martin; Unterhalt, Michael; Hoster, Eva; Hiddemann, Wolfgang; Weigert, Oliver (2019): Impact of age on clinical risk scores in follicular lymphoma. In: Blood Advances, Vol. 3, No. 7: pp. 1033-1038

Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Bararia, Deepak; Häbe, Sarah; Hellmuth, Johannes C.; Kridel, Robert; Gascoyne, Randy; Schmidt, Christian; Zöllner, Anna; Buske, Christian; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang; Hoster, Eva; Weigert, Oliver (2018): Impact of age on genetics and treatment efficacy in follicular lymphoma. In: Haematologica

Jurinovic, Vindi; Metzner, Bernd; Pfreundschuh, Michael; Schmitz, Norbert; Wandt, Hannes; Keller, Ulrich; Dreger, Peter; Dreyling, Martin; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Weigert, Oliver (2018): Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group. In: Biology of Blood and Marrow Transplantation

Bräss, Jan; Amler, Susanne; Kreuzer, Karl-Anton; Spiekermann, Karsten; Lindemann, Hans Walter; Lengfelder, Eva; Graeven, Ullrich; Staib, Peter; Ludwig, Wolf-Dieter; Biersack, Harald; Ko, Yon-Dschun; Uppenkamp, Michael J.; Wit, Maike de; Korsten, Stefan; Peceny, Rudolf; Gaska, Tobias; Schiel, Xaver; Behringer, Dirk M.; Kiehl, Michael G.; Zinngrebe, Bettina; Meckenstock, Gerald; Römer, Eva; Medgenberg, Dirk; Spaeth-Schwalbe, Ernst; Massenkeil, Gero; Hindahl, Heidrun; Schwerdtfeger, Rainer; Trenn, Guido; Sauerland, Cristina; Koch, Raphael; Lablans, Martin; Faldum, Andreas; Görlich, Dennis; Bohlander, Stefan K.; Schneider, Stephanie; Dufour, Annika; Buske, Christian; Fiegl, Michael; Subklewe, Marion; Bräss, Birgit; Unterhalt, Michael; Baumgartner, Anja; Wörmann, Bernhard; Beelen, Dietrich; Hiddemann, Wolfgang (2018): Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. In: Leukemia, Vol. 32, No. 12: pp. 2558-2571

Leich, E.; Hoster, Eva; Wartenberg, M.; Unterhalt, Michael; Siebert, R.; Koch, K.; Klapper, Wolfram; Engelhard, Marianne; Puppe, B.; Horn, Heike; Staiger, A. M.; Stuhlmann-Laeisz, C.; Bernd, Heinz Wolfram; Feller, A. C.; Hummel, Martina; Lenze, D.; Stein, H.; Hartmann, S.; Hansmann, Martin-Leo; Möller, P.; Hiddemann, Wolfgang; Dreyling, Martin; Ott, German; Rosenwald, Andreas (2016): Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. In: Leukemia, Vol. 30, No. 4: pp. 854-860

Hoster, Eva; Rosenwald, Andreas; Berger, F.; Bernd, Heinz Wolfram; Hartmann, S.; Loddenkemper, Christoph; Barth, Thomas E. F.; Brousse, N.; Pileri, S.; Rymkiewicz, G.; Kodet, Roman; Stilgenbauer, S.; Forstpointner, R.; Thieblemont, C.; Hallek, M.; Coiffier, B.; Vehling-Kaiser, U.; Bouabdallah, R.; Kanz, L.; Pfreundschuh, M.; Schmidt, C.; Ribrag, Vincent; Hiddemann, Wolfgang; Unterhalt, Michael; Kluin-Nelemans, J. C.; Hermine, Olivier; Dreyling, Martin; Klapper, Wolfram (2016): Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. In: Journal of Clinical Oncology, Vol. 34, No. 12: pp. 1386-1394

Hiddemann, Wolfgang; Hoster, Eva; Schmidt, C.; Dreyling, Martin; Unterhalt, Michael (2016): Aktuelle Therapiestrategien beim follikulären Lymphom. In: Internist, Vol. 57, No. 3: pp. 222-229

Koch, K.; Hoster, Eva; Ziepert, M.; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Bernd, W.; Stein, H.; Pöschel, V.; Dreyling, Martin; Trümper, L.; Löffler, M.; Schmitz, N.; Hiddemann, Wolfgang; Pfreundschuh, M.; Klapper, Wolfram (2016): Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. In: Annals of Oncology, Vol. 27, No. 7: pp. 1323-1329

Jurinovic, Vindi; Kridel, R.; Staiger, A. M.; Szczepanowski, M.; Horn, Heike; Dreyling, Martin; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Zelenetz, A. D.; Barr, P. M.; Friedberg, J. W.; Ansell, S.; Sehn, L. H.; Connors, J. M.; Gascoyne, R. D.; Hiddemann, Wolfgang; Unterhalt, Michael; Weinstock, D. M.; Weigert, O. (2016): Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. In: Blood, Vol. 128, No. 8: pp. 1112-1120

Hermine, Olivier; Hoster, Eva; Walewski, J.; Bosly, A.; Stilgenbauer, S.; Thieblemont, C.; Szymczyk, Michal; Bouabdallah, R.; Kneba, M.; Hallek, M.; Salles, G.; Feugier, P.; Ribrag, Vincent; Birkmann, J.; Forstpointner, R.; Haioun, C.; Hänel, M.; Casasnovas, R. O.; Finke, J.; Peter, N.; Bouabdallah, K.; Sebban, C.; Fischer, T.; Dührsen, U.; Metzner, B.; Maschmeyer, G.; Kanz, L.; Schmidt, C.; Delarue, R.; Brousse, N.; Klapper, Wolfram; Macintyre, E.; Delfau-Larue, M. H.; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin (2016): Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. In: Lancet, Vol. 388, No. 10044: pp. 565-575

Pastore, A.; Jurinovic, Vindi; Kridel, R.; Hoster, Eva; Staiger, A. M.; Szczepanowski, M.; Pott, Christiane; Kopp, N.; Murakami, M.; Horn, Heike; Leich, E.; Moccia, A. A.; Mottok, A.; Sunkavalli, A.; van Hummelen, P.; Ducar, M.; Ennishi, D.; Shulha, H. P.; Hother, C.; Connors, J. M.; Sehn, L. H.; Dreyling, Martin; Neuberg, D.; Moller, P.; Feller, A. C.; Hansmann, Martin-Leo; Stein, H.; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang; Gascoyne, R. D.; Weinstock, D. M.; Weigert, O. (2015): Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. In: Lancet Oncology, Vol. 16, No. 9: pp. 1111-1122

Delfau-Larue, M. H.; Klapper, Wolfram; Berger, F.; Jardin, F.; Briere, J.; Salles, G.; Casasnovas, O.; Feugier, P.; Haioun, C.; Ribrag, Vincent; Thieblemont, C.; Unterhalt, Michael; Dreyling, Martin; Macintyre, E.; Pott, Christiane; Hermine, Olivier; Hoster, Eva (2015): High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma. In: Blood, Vol. 126, No. 5: pp. 604-611

Hoster, Eva; Geisler, C. H.; Doorduijn, J.; van der Holt, B.; Walewski, J.; Bloehdorn, J.; Ribrag, Vincent; Salles, G.; Hallek, M.; Pott, Christiane; Szymczyk, Michal; Kolstad, A.; Laurell, A.; Raty, R.; Jerkeman, M.; Van’t Veer, M.; Kluin-Nelemans, J. C.; Klapper, Wolfram; Unterhalt, Michael; Dreyling, Martin; Hermine, Olivier (2015): Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. In: Leukemia, Vol. 30, No. 6: pp. 1428-1430

Wehkamp, Ulrike; Pott, Christiane; Unterhalt, Michael; Koch, Karoline; Weichenthal, Michael; Klapper, Wolfram; Oschlies, Ilske (2015): Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type. In: American Journal of Surgical Pathology, Vol. 39, No. 8: pp. 1093-1101 [PDF, 914kB]

Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Klapper, Wolfram; Vogt, N.; Delfau-Larue, M. H.; Hutter, Grit; Cheah, C.; Chiappella, A.; Cortelazzo, Sergio; Pott, Christiane; Hess, G.; Visco, C.; Vitolo, U.; Klener, P.; Aurer, I.; Unterhalt, Michael; Ribrag, Vincent; Hoster, Eva; Hermine, Olivier (2013): Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network. In: Leukemia & Lymphoma, Vol. 54, No. 4: pp. 699-707

Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Kakadia, P. M.; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang; Spiekermann, Karsten (2012): The FLT3ITD level has a high prognostic impact in NPM1 mutated, but not NPM1 unmutated AML with a normal karyotype. In: Blood, Vol. 119, No. 19: pp. 4383-4386

Kluin-Nelemans, H. C.; Hoster, Eva; Hermine, Olivier; Walewski, J.; Trneny, Marek; Geisler, C. H.; Stilgenbauer, S.; Thieblemont, C.; Vehling-Kaiser, U.; Doorduijn, J. K.; Coiffier, B.; Forstpointner, R.; Tilly, H.; Kanz, L.; Feugier, P.; Szymczyk, Michal; Hallek, M.; Kremers, S.; Lepeu, G.; Sanhes, L.; Zijlstra, J. M.; Bouabdallah, R.; Lugtenburg, P. J.; Macro, M.; Pfreundschuh, M.; Prochazka, V.; Di Raimondo, F.; Ribrag, Vincent; Uppenkamp, M.; Andre, M.; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin (2012): Treatment of older patients with mantle-cell lymphoma. In: New England Journal of Medicine / NEJM, Vol. 367, No. 6: pp. 520-531

Koch, K.; Hoster, Eva; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Engelhard, Marianne; Hiddemann, Wolfgang; Klapper, Wolfram (2012): The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease. In: Human Pathology, Vol. 43, No. 12: pp. 2274-2281

Witzens-Harig, Mathias; Hensel, Manfred; Unterhalt, Michael; Herfarth, Klaus (2011): Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial. In: BMC Cancer 11:87 [PDF, 278kB]

Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Hartmann, Elena; Salaverria, Itziar; Hutter, Grit; Perez-Galan, P.; Roue, G.; Pott, Christiane; Le Gouill, Steven; Cortelazzo, Sergio; Rule, S.; Hess, G.; Zaja, F.; Vitolo, U.; Szymczyk, Michal; Walewski, J.; Ribrag, Vincent; Unterhalt, Michael; Hermine, Olivier; Hoster, Eva (2011): Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network. In: Leukemia & Lymphoma, Vol. 52, No. 12: pp. 2226-2236

Jin, M. K.; Hoster, Eva; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang; Klapper, Wolfram (2011): Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome. In: Histopathology, Vol. 58, No. 4: pp. 586-592

Pott, Christiane; Hoster, Eva; Delfau-Larue, M. H.; Beldjord, K.; Böttcher, S.; Asnafi, V.; Plonquet, A.; Siebert, R.; Callet-Bauchu, E.; Andersen, N.; van Dongen, J. J.; Klapper, Wolfram; Berger, F.; Ribrag, Vincent; van Hoof, A. L.; Trneny, Marek; Walewski, J.; Dreger, P.; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, M.; Kluin-Nelemans, H. C.; Hermine, Olivier; Macintyre, E.; Dreyling, Martin (2010): Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. In: Blood, Vol. 115, No. 16: pp. 3215-3223

Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Fritsch, S.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang; Spiekermann, Karsten (2009): NPM1, but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high risk myelodysplastic syndrome (MDS). In: Blood, Vol. 113, No. 21: pp. 5250-5253

Buske, C.; Hoster, Eva; Dreyling, Martin; Eimermacher, H.; Wandt, H.; Metzner, B.; Fuchs, R.; Bittenbring, J.; Wörmann, Bernhard; Hohloch, K.; Hess, G.; Ludwig, W. D.; Schimke, J.; Schmitz, S.; Kneba, M.; Reiser, M.; Graeven, U.; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang (2009): The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). In: Leukemia, Vol. 23, No. 1: pp. 153-161

Klapper, Wolfram; Hoster, Eva; Determann, Olaf; Oschlies, Ilske; van der Laak, Jeroen; Berger, F.; Bernd, Heinz Wolfram; Cabeçadas, José; Campo, Elias; Cogliatti, Sergio; Hansmann, Martin-Leo; Kluin, Philip M.; Kodet, Roman; Krivolapov, Yuri A.; Loddenkemper, Christoph; Stein, H.; Moeller, P.; Barth, Thomas E. F.; Mueller-Hermelink, K.; Rosenwald, Andreas; Pileri, S.; Ralfkiaer, E.; Rymkiewicz, G.; van Krieken, Johan H.; Wacker, Hans Heinrich; Unterhalt, Michael; Hiddemann, Wolfgang; Dreyling, Martin (2009): Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. In: Journal of Hematopathology, Vol. 2, No. 2: pp. 103-111

Herrmann, Annina; Hoster, Eva; Zwingers, T.; Brittinger, G.; Engelhard, Marianne; Meusers, P.; Reiser, M.; Forstpointner, R.; Metzner, B.; Peter, N.; Wörmann, Bernhard; Trümper, L.; Pfreundschuh, M.; Einsele, H.; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin (2009): Improvement of overall survival in advanced stage mantle cell lymphoma. In: Journal of Clinical Oncology, Vol. 27, No. 4: pp. 511-518

Determann, Olaf; Hoster, Eva; Ott, German; Wolfram-Bernd, H.; Loddenkemper, Christoph; Hansmann, Martin-Leo; Barth, Thomas E. F.; Unterhalt, Michael; Hiddemann, Wolfgang; Dreyling, Martin; Klapper, Wolfram (2008): Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. In: Blood, Vol. 111, No. 4: pp. 2385-2387

Böttcher, S.; Ritgen, M.; Buske, S.; Gesk, S.; Klapper, Wolfram; Hoster, Eva; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Siebert, R.; Kneba, M.; Pott, Christiane (2008): Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. In: Haematologica, Vol. 93, No. 4: pp. 551-559

Hoster, Eva; Dreyling, Martin; Klapper, Wolfram; Gisselbrecht, C.; van Hoof, A.; Kluin-Nelemans, H. C.; Pfreundschuh, M.; Reiser, M.; Metzner, B.; Einsele, H.; Peter, N.; Jung, W.; Wörmann, Bernhard; Ludwig, W. D.; Dührsen, U.; Eimermacher, H.; Wandt, H.; Hasford, Joerg; Hiddemann, Wolfgang; Unterhalt, Michael (2008): A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Erratum. In: Blood, Vol. 111, No. 2: pp. 558-565

Hoster, Eva; Dreyling, Martin; Unterhalt, Michael (2008): Response: Statistical power and validation of the MIPI. In: Blood, Vol. 112, No. 6: pp. 2583-2584

Nickenig, C.; Dreyling, Martin; Hoster, Eva; Ludwig, W. D.; Dörken, B.; Freund, M.; Huber, C.; Ganser, A.; Trümper, L.; Forstpointner, R.; Unterhalt, Michael; Hiddemann, Wolfgang (2007): Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas: Results of a randomized comparison by the German Low-Grade Lymphoma Study Group. In: Annals of Oncology, Vol. 18, No. 1: pp. 136-142

Klapper, Wolfram; Hoster, Eva; Rolver, L.; Schrader, C.; Janssen, D.; Tiemann, M.; Bernd, Heinz Wolfram; Determann, Olaf; Hansmann, Martin-Leo; Möller, P.; Feller, A.; Stein, H.; Wacker, Hans Heinrich; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang; Ott, German (2007): Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. In: Journal of Clinical Oncology, Vol. 25, No. 22: pp. 3330-3336

Nickenig, C.; Dreyling, Martin; Hoster, Eva; Pfreundschuh, M.; Trumper, L.; Reiser, M.; Wandt, H.; Lengfelder, E.; Unterhalt, Michael; Hiddemann, Wolfgang (2006): Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group. In: Cancer, Vol. 107, No. 5: pp. 1014-1022

Buske, C.; Hoster, Eva; Dreyling, Martin; Hasford, Joerg; Unterhalt, Michael; Hiddemann, Wolfgang (2006): The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc. In: Blood, Vol. 108, No. 5: pp. 1504-1508

Lenz, G.; Dreyling, Martin; Hoster, Eva; Wörmann, Bernhard; Dührsen, U.; Metzner, B.; Eimermacher, H.; Neubauer, A.; Wandt, H.; Steinhauer, H.; Martin, S.; Heidemann, E.; Aldaoud, A.; Parwaresch, R.; Hasford, Joerg; Unterhalt, Michael; Hiddemann, Wolfgang (2005): Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). In: Journal of Clinical Oncology, Vol. 23, No. 23: pp. 1984-1992

Dreyling, Martin; Lenz, G.; Hoster, Eva; Van-Hoof, A.; Gisselbrecht, C.; Schmits, R.; Metzner, B.; Truemper, L.; Reiser, M.; Steinhauer, H.; Boiron, J. M.; Boogaerts, M. A.; Aldaoud, A.; Silingardi, V.; Kluin-Nelemans, H. C.; Hasford, Joerg; Parwaresch, R.; Unterhalt, Michael; Hiddemann, Wolfgang (2005): Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. In: Blood, Vol. 105, No. 7: pp. 2677-2684

Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Forstpointner, R.; Wandt, H.; Freund, M.; Hess, G.; Truemper, L.; Diehl, V.; Kropff, M.; Kneba, M.; Schmitz, N.; Metzner, B.; Pfirrmann, Markus; Unterhalt, Michael; Hiddemann, Wolfgang (2004): Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. In: Blood, Vol. 104, No. 9: pp. 2667-2674

Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Haferlach, T.; Hasford, Joerg; Unterhalt, Michael; Hiddemann, Wolfgang (2004): Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group. In: Journal of Clinical Oncology, Vol. 22, No. 24: pp. 4926-4933

This list was generated on Tue May 26 00:17:41 2020 CEST.